Trial Profile
Kinetics, Biodistribution, Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold Kit, in Healthy Male Volunteers and Patients With Limited Recurrent Prostate Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Prostate cancer
- Focus Pharmacokinetics
- 23 Oct 2020 Status changed from recruiting to completed.
- 08 Feb 2018 Status changed from not yet recruiting to recruiting.
- 29 Dec 2017 Planned initiation date changed from 11 Dec 2017 to 15 Jan 2018.